GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » PensionAndRetirementBenefit

Zahravi Pharmacutical Co (XTEH:DZAH1) PensionAndRetirementBenefit : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co PensionAndRetirementBenefit?

Zahravi Pharmacutical Co's PensionAndRetirementBenefit for the quarter that ended in . 20 was IRR0.00 Mil.


Zahravi Pharmacutical Co PensionAndRetirementBenefit Historical Data

The historical data trend for Zahravi Pharmacutical Co's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co PensionAndRetirementBenefit Chart

Zahravi Pharmacutical Co Annual Data
Trend
PensionAndRetirementBenefit

Zahravi Pharmacutical Co Semi-Annual Data
PensionAndRetirementBenefit

Zahravi Pharmacutical Co PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines